Literature DB >> 11167230

Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation.

M Lövestam-Adrian1, N Svendenius, E Agardh.   

Abstract

PURPOSE: To study patients treated with panretinal photocoagulation regarding contrast sensitivity and visual recovery time after exposure to glare.
METHODS: To compare contrast sensitivity and visual recovery-time after exposure to glare in eyes (n=20) from 20 type 1 diabetic patients treated with panretinal photocoagulation for proliferative retinopathy with eyes (n= 19) from 19 un-treated type 1 diabetic patients. Contrast sensitivity was tested with a low contrast acuity chart, before and during exposure to either a uniform background illumination or a spotlight. Visual recovery time was defined as the time required to regain baseline visual acuity during light exposure.
RESULTS: Contrast thresholds values were higher in eyes treated with panretinal photocoagulation compared to un-treated eyes before illumination 4.2 +/- 1.2% vs. 3.1 +/- 1.7% (p=0.006), during background illumination 5.8 +/- 5.1% vs. 3.9 +/- 4.8% (p=0.001), and during spotlight exposure 5.6 +/- 2.2% vs. 3.2 +/- 1.8% (p<0.001). Furthermore, recovery time was longer both during background illumination, 20; 5-50 sec vs. 2; 2-80 sec. (md;range), (p<0.001) and during spotlight illumination 27; 5-70 sec vs. 2;1-60 sec. (md;range) (p<0.001).
CONCLUSION: Eyes treated with panretinal photocoagulation had higher contrast threshold levels at baseline and during glare, as well as a prolonged visual recovery time compared to un-treated eyes with mild background retinopathy.

Entities:  

Mesh:

Year:  2000        PMID: 11167230     DOI: 10.1034/j.1600-0420.2000.078006672.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  5 in total

1.  Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes.

Authors:  Evangelia Papavasileiou; Samaneh Davoudi; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; James G Wilson; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-15       Impact factor: 3.117

2.  Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.

Authors:  Monica Lövestam-Adrian; Sten Andréasson; Vesna Ponjavic
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

Review 3.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.

Authors:  Grace E Boynton; Maxwell S Stem; Leon Kwark; Gregory R Jackson; Sina Farsiu; Thomas W Gardner
Journal:  Ophthalmology       Date:  2015-01-17       Impact factor: 12.079

Review 5.  Evaluation of Laser Effects on the Human Body After Laser Therapy.

Authors:  Ensieh Khalkhal; Mohammadreza Razzaghi; Mohammad Rostami-Nejad; Majid Rezaei-Tavirani; Hazhir Heidari Beigvand; Mostafa Rezaei Tavirani
Journal:  J Lasers Med Sci       Date:  2020-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.